Cargando…

Progress and Future Trends in PET/CT and PET/MRI Molecular Imaging Approaches for Breast Cancer

Breast cancer is a major disease with high morbidity and mortality in women worldwide. Increased use of imaging biomarkers has been shown to add more information with clinical utility in the detection and evaluation of breast cancer. To date, numerous studies related to PET-based imaging in breast c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ming, Yue, Wu, Nan, Qian, Tianyi, Li, Xiao, Wan, David Q., Li, Caiying, Li, Yalun, Wu, Zhihong, Wang, Xiang, Liu, Jiaqi, Wu, Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435066/ https://www.ncbi.nlm.nih.gov/pubmed/32903496 http://dx.doi.org/10.3389/fonc.2020.01301

Ejemplares similares

Value of (18)F-FDG PET/MRI in the Preoperative Assessment of Resectable Esophageal Squamous Cell Carcinoma: A Comparison With (18)F-FDG PET/CT, MRI, and Contrast-Enhanced CT
por: Wang, Fei, et al.
Publicado: (2022)

The Value of (18)F-FDG PET/CT and Abdominal PET/MRI as a One-Stop Protocol in Patients With Potentially Resectable Colorectal Liver Metastases
por: Zhou, Nina, et al.
Publicado: (2021)

Pretherapeutic Assessment of Pancreatic Cancer: Comparison of FDG PET/CT Plus Delayed PET/MR and Contrast-Enhanced CT/MR
por: Zhang, Zaizhu, et al.
Publicado: (2022)

Trimodality PET/CT/MRI and Radiotherapy: A Mini-Review
por: Decazes, Pierre, et al.
Publicado: (2021)

The role of PET/CT in radiotherapy for nasopharyngeal carcinoma
por: Li, Hongjia, et al.
Publicado: (2022)

(68)Ga-PSMA-11 PET/CT versus (68)Ga-PSMA-11 PET/MRI for the detection of biochemically recurrent prostate cancer: a systematic review and meta-analysis
por: Huang, Ruizhe, et al.
Publicado: (2023)

Application of FDG-PET/CT in Radiation Oncology
por: Li, Jun, et al.
Publicado: (2013)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

[18F]FDG PET/CT versus [18F]FDG PET/MRI for the diagnosis of colorectal liver metastasis: A systematic review and meta-analysis
por: Miao, Zhi, et al.
Publicado: (2023)

A Pilot Study of (18)F-DCFPyL PET/CT or PET/MRI and Ultrasound Fusion Targeted Prostate Biopsy for Intra-Prostatic PET-Positive Lesions
por: Liu, Yachao, et al.
Publicado: (2021)

The value of combined PET/MRI, CT and clinical metabolic parameters in differentiating lung adenocarcinoma from squamous cell carcinoma
por: Tang, Xin, et al.
Publicado: (2022)

4D PET/CT as a Strategy to Reduce Respiratory Motion Artifacts in FDG-PET/CT
por: Chi, Alexander, et al.
Publicado: (2014)

The progress of PET/MRI in clinical management of patients with pancreatic malignant lesions
por: Li, Jindan, et al.
Publicado: (2023)

Diagnostic Value of Delayed PET/MR in Liver Metastasis in Comparison With PET/CT
por: Zhou, Nina, et al.
Publicado: (2021)

First experiences with PET-MRI/CT in radiotherapy planning for cervical cancer
por: Scharl, Sophia, et al.
Publicado: (2022)

The role of PET/CT in cervical cancer
por: Herrera, Fernanda G., et al.
Publicado: (2013)

Prognostic values of ALDOB expression and (18)F-FDG PET/CT in hepatocellular carcinoma
por: Jia, Wenzhi, et al.
Publicado: (2022)

Application Value of PET/CT and MRI in the Diagnosis and Treatment of Patients With Synchronous Multiple Pulmonary Ground-Glass Nodules
por: Xie, Shaonan, et al.
Publicado: (2022)

Dynamic PET/CT Imaging of (68)Ga-FAPI-04 in Chinese Subjects
por: Wang, Shuailiang, et al.
Publicado: (2021)

Tailoring the clinical management of colorectal cancer by (18)F-FDG PET/CT
por: Shi, Yang, et al.
Publicado: (2022)

PET/CT and PET/MRI in ophthalmic oncology (Review)
por: Kalemaki, Maria S., et al.
Publicado: (2020)

PET/CT in Multiple Myeloma: Beyond FDG
por: Matteucci, Federica, et al.
Publicado: (2021)

Choline PET/CT in recurrent prostate cancer
por: Detti, Beatrice, et al.
Publicado: (2023)

Skeletal Metastasis as Detected by 18F-FDG PET with Negative CT of the PET/CT: Frequency and Impact on Cancer Staging and/or Management
por: Ahmed, Fatma, et al.
Publicado: (2016)

Imaging of Tumor Hypoxia With Radionuclide-Labeled Tracers for PET
por: Huang, Yuan, et al.
Publicado: (2021)

Comparison of PET/CT and MRI in the Diagnosis of Bone Metastasis in Prostate Cancer Patients: A Network Analysis of Diagnostic Studies
por: Liu, Fanxiao, et al.
Publicado: (2021)

Frontiers and hotspots of (18)F-FDG PET/CT radiomics: A bibliometric analysis of the published literature
por: Liu, Xinghai, et al.
Publicado: (2022)

Radiomics Analysis of PET and CT Components of (18)F-FDG PET/CT Imaging for Prediction of Progression-Free Survival in Advanced High-Grade Serous Ovarian Cancer
por: Wang, Xihai, et al.
Publicado: (2021)

Comparing PET/MRI with PET/CT for Pretreatment Staging of Gastric Cancer
por: Liu, Yi, et al.
Publicado: (2019)

Whole-Body MRI vs. PET/CT for the Detection of Bone Metastases in Patients With Prostate Cancer: A Systematic Review and Meta-Analysis
por: Zhan, Yuefu, et al.
Publicado: (2021)

PET/CT in Radiotherapy Planning for Head and Neck Cancer
por: Newbold, Katie, et al.
Publicado: (2012)

Radioembolization and the Dynamic Role of (90)Y PET/CT
por: Pasciak, Alexander S., et al.
Publicado: (2014)

FAPI PET/CT in the Diagnosis of Abdominal and Pelvic Tumors
por: Yang, Tianshuo, et al.
Publicado: (2022)

PET/CT Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients
por: Rong, Xiaoxiang, et al.
Publicado: (2022)

Prospective comparison of (68)Ga-FAPI-04 and (18)F-FDG PET/CT for tumor staging in nasopharyngeal carcinoma
por: Ding, Haoyuan, et al.
Publicado: (2022)

Comparison of the diagnostic efficiency for local recurrence of rectal cancer using CT, MRI, PET and PET-CT: A systematic review protocol
por: Shao, Hongsheng, et al.
Publicado: (2018)

Survival effect of pre-RT PET-CT on cervical cancer: Image-guided intensity-modulated radiation therapy era
por: Su, Chih-Hsiung, et al.
Publicado: (2023)

The Evolving Role of (18)F-FDG PET/CT in Diagnosis and Prognosis Prediction in Progressive Prostate Cancer
por: Shen, Kai, et al.
Publicado: (2021)

Recent and current advances in PET/CT imaging in the field of predicting epidermal growth factor receptor mutations in non-small cell lung cancer
por: Hu, Na, et al.
Publicado: (2022)

Potential (18)F-RGD PET/CT and DCE-MRI Imaging-Based Biomarkers for Postoperative Survival Prediction Among Patients With Newly Diagnosed Glioblastoma Treated With Bevacizumab and Chemoradiotherapy
por: Li, Li, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gsqsk62umebntg08brlbdn9jkp